Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (BMY), HCA Healthcare (HCA) and Intuitive Surgical (ISRG)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bristol-Myers Squibb (BMY – Research Report), HCA Healthcare (HCA – Research Report) and Intuitive Surgical (ISRG – Research Report).
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Bristol-Myers Squibb (BMY)
In a report released today, Terence Flynn from Morgan Stanley maintained a Sell rating on Bristol-Myers Squibb, with a price target of $37.00. The company’s shares closed last Tuesday at $55.56.
According to TipRanks.com, Flynn is a 5-star analyst with an average return of
Currently, the analyst consensus on Bristol-Myers Squibb is a Moderate Buy with an average price target of $57.13.
See the top stocks recommended by analysts >>
HCA Healthcare (HCA)
In a report released today, Craig Hettenbach from Morgan Stanley maintained a Sell rating on HCA Healthcare, with a price target of $425.00. The company’s shares closed last Tuesday at $505.84.
Hettenbach has an average return of
According to TipRanks.com, Hettenbach is ranked #3130 out of 12040 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for HCA Healthcare with a $523.47 average price target.
Intuitive Surgical (ISRG)
Morgan Stanley analyst Patrick Wood maintained a Buy rating on Intuitive Surgical today and set a price target of $650.00. The company’s shares closed last Tuesday at $525.04.
According to TipRanks.com, Wood is a 3-star analyst with an average return of
Currently, the analyst consensus on Intuitive Surgical is a Strong Buy with an average price target of $652.73, implying a 22.6% upside from current levels. In a report issued on January 13, TipRanks – xAI also initiated coverage with a Buy rating on the stock with a $664.00 price target.
